AAPL
45
3
STZ
58
3
EMR
77
-2
EXPE
96
-3
DTE
38
-4
KLAC
45
-4
DIS
62
2
RRC
60
-3
R
77
2
XOM
51
3
GS
75
-4
HES
66
3
GPC
40
2
STX
52
-4
XEL
65
-2
EMN
50
-2
STI
31
19
AES
41
2
ADI
45
-5
BK
72
-2
AAPL
45
3
STZ
58
3
EMR
77
-2
EXPE
96
-3
DTE
38
-4
KLAC
45
-4
DIS
62
2
RRC
60
-3
R
77
2
XOM
51
3
GS
75
-4
HES
66
3
GPC
40
2
STX
52
-4
XEL
65
-2
EMN
50
-2
STI
31
19
AES
41
2
ADI
45
-5
BK
72
-2
Financhill
Back

Emergent BioSolutions Quote, Financials, Valuation and Earnings

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Buy
57

EBS
Emergent BioSolutions

Last Price:
9.27
Seasonality Move:
10.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.

Emergent BioSolutions Price Quote

$9.27
-0.70 (-7.02%)
(Updated: November 14, 2024 at 5:30 PM ET)

Emergent BioSolutions Key Stats

Buy
57
Emergent BioSolutions (EBS) is a Buy
Day range:
$9.94 - $11.02
52-week range:
$1.42 - $15.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.53
P/B ratio:
1.49%
Volume:
1.5M
Avg. volume:
1.4M
1-year change:
447.8%
Market cap:
$576.2M
Revenue:
$1B
EPS:
$-11.24

How Much Does Emergent BioSolutions Make?

Is Emergent BioSolutions Growing As A Company?

  • What Is Emergent BioSolutions's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.25%
  • What Is Emergent BioSolutions's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Emergent BioSolutions Stock Price Performance

What Is Emergent BioSolutions 52-Week High & Low?

Emergent BioSolutions Price To Free Cash Flow

Is It Risky To Buy Emergent BioSolutions?

Is Emergent BioSolutions Cash Flow Positive?

  • What Is EBS Cash Flow From Operations?
    Cash flow from operations (TTM) is $77M
  • What Is Emergent BioSolutions’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$48.5M
  • What Is Emergent BioSolutions’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$45.7M

Emergent BioSolutions Return On Invested Capital

  • Is Management Doing A Good Job?
    EBS return on invested capital is -37.89%
  • What Is Emergent BioSolutions Return On Assets?
    ROA measures how assets are converting to revenues and is -31.86%
  • What Is EBS Return On Equity?
    ROE is a measure of profitability and is -87.53%

Emergent BioSolutions Earnings Date & Stock Price

Emergent BioSolutions Competitors

Emergent BioSolutions Dividend Yield

Emergent BioSolutions Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 874.53%
Revenue: -25.11% -1.24%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 12.00
Upside from Last Price: 20.36%

Major Shareholders

  • How many EBS shares are owned by institutional investors?
    42.8M EBS shares are owned by institutional investors
  • How many EBS shares are owned by insiders?
    3.9M EBS shares are owned by insiders